These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34660321)

  • 1. Next Generation Sequencing of Tumor and Matched Plasma Samples: Identification of Somatic Variants in ctDNA From Ovarian Cancer Patients.
    Barbosa A; Pinto P; Peixoto A; Guerra J; Pinheiro M; Santos C; Pinto C; Escudeiro C; Bartosch C; Santos R; Brandão A; Silva J; Teixeira MR
    Front Oncol; 2021; 11():754094. PubMed ID: 34660321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent Tissue and Circulating Tumor DNA Molecular Profiling to Detect Guideline-Based Targeted Mutations in a Multicancer Cohort.
    Iams WT; Mackay M; Ben-Shachar R; Drews J; Manghnani K; Hockenberry AJ; Cristofanilli M; Nimeiri H; Guinney J; Benson AB
    JAMA Netw Open; 2024 Jan; 7(1):e2351700. PubMed ID: 38252441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous mutation pattern in tumor tissue and circulating tumor DNA warrants parallel NGS panel testing.
    Guo Q; Wang J; Xiao J; Wang L; Hu X; Yu W; Song G; Lou J; Chen J
    Mol Cancer; 2018 Aug; 17(1):131. PubMed ID: 30153823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of genomic alterations between tumor tissue and circulating tumor DNA by next-generation sequencing.
    Chang YS; Fang HY; Hung YC; Ke TW; Chang CM; Liu TY; Chen YC; Chao DS; Huang HY; Chang JG
    J Cancer Res Clin Oncol; 2018 Nov; 144(11):2167-2175. PubMed ID: 30203147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and monitoring of somatic mutations in circulating cell-free tumor DNA in lung cancer patients.
    Francaviglia I; Magliacane G; Lazzari C; Grassini G; Brunetto E; Dal Cin E; Girlando S; Medicina D; Smart CE; Bulotta A; Gregorc V; Pecciarini L; Doglioni C; Cangi MG
    Lung Cancer; 2019 Aug; 134():225-232. PubMed ID: 31319985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of circulating tumor DNA from breast cancer patients before and after surgery and following adjuvant chemotherapy.
    Zelinova K; Jagelkova M; Laucekova Z; Bobrovska M; Dankova Z; Grendar M; Dokus K
    Mol Clin Oncol; 2020 Oct; 13(4):26. PubMed ID: 32765873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of Somatic Genomic Alterations Between Tissue Genomics and ctDNA Employing Next-Generation Sequencing: Analysis of Lung and Gastrointestinal Cancers.
    Toor OM; Ahmed Z; Bahaj W; Boda U; Cummings LS; McNally ME; Kennedy KF; Pluard TJ; Hussain A; Subramanian J; Masood A
    Mol Cancer Ther; 2018 May; 17(5):1123-1132. PubMed ID: 29500272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical performance evaluation of a commercial next generation sequencing liquid biopsy platform using plasma ctDNA, reference standards, and synthetic serial dilution samples derived from normal plasma.
    Verma S; Moore MW; Ringler R; Ghosal A; Horvath K; Naef T; Anvari S; Cotter PD; Gunn S
    BMC Cancer; 2020 Oct; 20(1):945. PubMed ID: 33004033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of circulating tumor DNA in epidermal growth factor receptor-TKI relapsed non-small cell lung cancer patients using next-generation sequencing and an analysis of the resistant mechanisms].
    Li Y; Zhang FS; Guo L; Ying JM
    Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):904-909. PubMed ID: 30522169
    [No Abstract]   [Full Text] [Related]  

  • 10. Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study.
    Pécuchet N; Zonta E; Didelot A; Combe P; Thibault C; Gibault L; Lours C; Rozenholc Y; Taly V; Laurent-Puig P; Blons H; Fabre E
    PLoS Med; 2016 Dec; 13(12):e1002199. PubMed ID: 28027313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Informed Approach Improved ctDNA Detection Rate in Resected Pancreatic Cancer.
    Watanabe K; Nakamura T; Kimura Y; Motoya M; Kojima S; Kuraya T; Murakami T; Kaneko T; Shinohara Y; Kitayama Y; Fukuda K; Hatanaka KC; Mitsuhashi T; Pittella-Silva F; Yamaguchi T; Hirano S; Nakamura Y; Low SK
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From Somatic Variants Toward Precision Oncology: An Investigation of Reporting Practice for Next-Generation Sequencing-Based Circulating Tumor DNA Analysis.
    Peng R; Zhang R; Horan MP; Zhou L; Chai SY; Pillay N; Tay KH; Badrick T; Li J
    Oncologist; 2020 Mar; 25(3):218-228. PubMed ID: 32162803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of circulating tumor DNA using a targeted 545-gene next generation sequencing panel in patients with gastric cancer.
    Lan J; Lu Y; Guan Y; Chang L; Yu Z; Qian H
    Oncol Lett; 2020 Mar; 19(3):2251-2257. PubMed ID: 32194723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective utilization of circulating tumor DNA testing enables disease monitoring in endometrial and ovarian carcinomas.
    Jamieson A; McConechy MK; Lum A; Senz J; Dowhy T; Huntsman DG; McAlpine JN
    J Gynecol Oncol; 2024 Jun; ():. PubMed ID: 38909641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma.
    Maron SB; Chase LM; Lomnicki S; Kochanny S; Moore KL; Joshi SS; Landron S; Johnson J; Kiedrowski LA; Nagy RJ; Lanman RB; Kim ST; Lee J; Catenacci DVT
    Clin Cancer Res; 2019 Dec; 25(23):7098-7112. PubMed ID: 31427281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Somatic Mutation Profiles Between Formalin-Fixed Paraffin Embedded Tissues and Plasma Cell-Free DNA from Ovarian Cancer Patients Before and After Surgery.
    Jagelkova M; Zelinova K; Laucekova Z; Bobrovska M; Dankova Z; Grendar M; Dokus K
    Biores Open Access; 2020; 9(1):73-79. PubMed ID: 32219013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing the efficacy of targeted next-generation sequencing in the identification of somatic mutations in circulating tumor DNA from different stages of lung cancer.
    Chen Y; Han T; Zhou Y; Mao B; Zhuang W
    Neoplasma; 2019 Jul; 66(4):652-660. PubMed ID: 31058536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The diagnostic and prognostic usage of circulating tumor DNA in operable hepatocellular carcinoma.
    An Y; Guan Y; Xu Y; Han Y; Wu C; Bao C; Zhou B; Wang H; Zhang M; Liu W; Qiu L; Han Z; Chen Y; Xia X; Wang J; Liu Z; Huang W; Yi X; Huang J
    Am J Transl Res; 2019; 11(10):6462-6474. PubMed ID: 31737198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concordance of circulating tumor DNA and matched formalin-fixed paraffin-embedded tumor tissue in gastric cancer as a predictor of recurrence.
    Seo SH; Park YS; Nam SK; Lee HS; Park DJ; Park KU
    Korean J Clin Oncol; 2023 Dec; 19(2):45-51. PubMed ID: 38229488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumour DNA detects somatic variants contributing to spatial and temporal intra-tumoural heterogeneity in head and neck squamous cell carcinoma.
    Payne KFB; Brotherwood P; Suriyanarayanan H; Brooks JM; Batis N; Beggs AD; Gendoo DMA; Mehanna H; Nankivell P
    Front Oncol; 2024; 14():1374816. PubMed ID: 38846976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.